Our Policy Work

 

The program consists of six tracks and fifty-one sessions. Please note that all sessions are subject to change. What follows are the session titles and descriptions. Click links for panelists.

Wednesday, October 3

9:00-4:00pm

Registration in Doerr Hosier

 4:00-5:30pm

 

Welcoming Remarks and Opening Session
Great Expectations: American Attitudes toward Personal Responsibility and Medicine. A new national poll conducted for the Aspen Health Forum by Zogby International will form the basis of this session on what Americans expect from their health care and medical science – and how they view their own role. (Opening Plenary - The Art and Humanity of Medicine)

           

 5:30-6:30pm

  Welcome Reception with Buffet
           

 6:30-8:00pm

  Dinner Break
           

 8:30-10:00pm

  Evening Special Event: Healthcare Re-imagined: Learning from Olympic Athletes. GE Healthcare is working with medical leaders in the global Olympic Movement to advance the use of innovative technologies that can provide insight into musculoskeletal injury assessment and the diagnosis and treatment of heart disease in the general population.  Join GE Healthcare CEO Joe Hogan, NBC sportscaster Jimmy Roberts, cardiologist Dr. Malissa Wood of Massachusetts General Hospital, Vancouver 2010 Chief Medical Officer Dr. Jack Taunton, U.S. Olympic Committee Games Medical Services Director Margaret Hunt and U.S. Olympic gold medalists, skier Picabo Street and swimmer Aaron Peirsol for interactive demonstrations and a discussion of how a focus on early health can benefit both elite athletes and consumers worldwide.

Thursday, October 4

 7:30-9:00am

  Cancer and the Sexes.  Nothing less than the very central human function of reproduction is at stake when the cancers of the sexes attack. Ovarian and testicular cancer remain notoriously hard to spot even as great strides have been made in the detection and prevention of cervical and prostate cancer, which continue to be among the most deadly forms. Breast cancer, too, remains very common. This frank discussion will explore the latest research in prevention, detection, therapy, and the ever-elusive cure. (Breakfast Tutorial - Frontiers in Medicine)
    Beyond the X-Ray: 21st Century Imaging. From their first appearance, methods of medical imaging have captured our imaginations. The fad of full-body MRI scans may be becoming passé. What will be the next revolutionary development in imaging? Learn how scientists are making the invisible visible. (Breakfast Tutorial - State of the Art Medical Science)
    From the Front Lines: Post-Traumatic Stress Disorder and the Legacy of Iraq. Here, our panelists will explore the health care consequences of the Iraq war for our families, communities and our society. (Breakfast Tutorial - The Art and Humanity of Medicine)
    The Damaged Brain: The Fight Against Neurodegeneration. Alzheimer’s Disease, Multiple Sclerosis, and Macular Degeneration each result from the loss of neurons, the electrically excitable nerve cells that process and transmit information. These diseases alter the lives of not only patients but also those who care for them. Find out what's being done to combat neurodegeneration. (Breakfast Tutorial - Frontiers in Medicine)
    Fitness and Nutrition: The Science of Metabolism.  Come hear how new knowledge about molecules such as insulin and leptin are changing the way scientists view fitness. Learn about the latest research, how your body works, how it stores fat, how it prevents diseases such as diabetes, and how it gets fit. This session will explore implications for longevity, how to get it and whether we should really want it. (Breakfast Tutorial - Science and Prevention)
             

9:15-11:00am

Keynote: The Human Element: A Candid Conversation about Pioneers of Modern Medicine. Intellectual curiosity, methodological rigor, hard work and even luck each play a role in science. Hear Nobel Prize recipients J. Michael Bishop and Peter Agre recount personal stories of discovery, including including amusing anecdotes about what surrounds “Eureka!” moments. Neen Hunt, president of The Lasker Foundation, will share additional insights on discoveries by Lasker awardees. (The Art and Humanity of Medicine)

           

 11:15-12:30pm

  The Mysterious Human Heart (daytime panel).  The beat of the human heart is literally the definition of life, but when the heart malfunctions it is also the leading cause of human illness. How are genetics, molecular biology and imaging reshaping how we define hypertension, heart disease, and stroke? Presented in partnership with AstraZeneca. (Tutorial - Frontiers in Medicine)
    The Promise of Stem Cells: Will the Body Become a Renewable Resource? Scientists are discovering how to make new organs from scratch. Will they be able to create perfectly matched replacements for diseased cells and organs? (Tutorial - State of the Art Medical Science)
    The Last Frontier: The Mind. From perception to volition, the brain influences our most complex functions and actions in ways we are only beginning to understand. What are new tools telling us about human cognition, brain health, and how we experience and respond to our environment? (Tutorial - State of the Art Medical Science)
    International Scientific Cooperation.  With every passing year, more and more scientific research and development is done in more and more places around the globe, and it’s hard to see that as anything but good. But how well is the research community integrating and communicating within its global ranks — disseminating learning, sharing data, and submitting work to peer review and criticism on a worldwide basis? Are we squeezing all of the possible benefit out of all of this spending and effort, or are we building a behemoth problem of right hands and left hands not knowing what one another are doing? (Tutorial - International Science)
    Easing the Burden: Does Health Care Cost Too Much and How Do We Pay for It? Health care spending continues to rise even as policymakers, government officials and business leaders debate the best ways to control costs and extend coverage to those without it. Adopting healthy lifestyles is part of the equation, but the question remains: How can we pay for all of the medicine we want? We consider options that will help us avoid the most expensive approach: inaction. (Tutorial - The Art and Humanity of Medicine)
     

12:30-2:00pm

Lunch and Plenary Session: The Hospital of the Future. Imagine patient rooms replete with wireless technology, “smart systems” that help avoid human error, and built environments designed to heighten personal care. Will the hospital of tomorrow even resemble the hospitals of today? What would it look like if George Jetson got sick? And how long before we realize such innovations? (Lunch Plenary - The Art and Humanity of Medicine)
Lunch and Plenary Session: Global Scientific Investment. The United States no longer stands alone in either the actual conduct or the funding of scientific research. In today’s world of increasingly multi-lateral medicine, how are we to get the most out of the ever-increasing investment in medical research and development? How are the best scientific partnerships forged? This session focuses on biotech investments around the globe and how, from business to academia, the capital markets can (and cannot) serve to promote efficient and productive research worldwide. (Lunch Plenary - International Science)
       

2:15-3:45pm

Tailor-Made Medicine: How genomic science will lead to personalizing treatment and cures. (Tutorial - The Art and Humanity of Medicine)
Science Versus the Biological Clock. Despite advances in medical research, we’re all getting older — but that hasn’t stopped the scientific search for the Fountain of Youth. Experts such as those on our panel are discovering genes central to the aging process. Their research may make it possible to slow the process of aging, but in the meantime we face a burgeoning population of older adults. This demographic shift has the potential to change medical research, health care, and our nation as a whole. (Tutorial - Frontiers in Medicine)
Getting What We Pay For: The Impact of Declining Public Investment in Medical Science Research. (Tutorial - From the Lab to You)
The Future of Nutrition: What your Body Needs You to Know Now. As childhood obesity increases and the baby boomers age, we are all more focused on prevention. Preventing obesity alone decreases cancer, heart disease and other chronic killers. Learn where the field of nutrition is heading, including new insights on the mind-body connection. (Tutorial - Science and Prevention)
Pandemic Influenza. The last major influenza pandemic occurred in 1918 and killed 20 to 40 million people worldwide. Nearly 90 years later, we are almost as helpless in facing this disease as we were back then. Experts from around the world will bring us up to date on how we plan to protect ourselves. From vaccine development to surveillance and detection to rapid response, this session will lay out the global plans to fight the next pandemic. (Tutorial - Frontiers in Medicine)
      

4:00-5:30pm

Keynote: Dangerous Liaisons: The Intersection of Environmental, Animal and Human Health. Outbreaks of the Ebola virus and bird flu in recent years have underscored that public health is inseparable from people’s relationships with their physical environment. Bill Frist explains why we should all be concerned about vectors of combined airborne, waterborne and food-chain contamination — no matter where they occur. (Keynote - International Science)
   

8:30-10:30pm

Evening Special Event: Fast Food Nation: A Film Screening Hosted by Eric Schlosser. Following the screening, Eric Schlosser will field questions about the film and the lessons it imparts. The film is based on his New York Times best-selling book of the same title. 

Evening Special Event: The Mysterious Human Heart. View an advance screening of this new PBS program two weeks before its national broadcast and hear from the producer about the cinematography challenges of showing the inner workings of this vital organ. Cardiology experts also will take part in the session and field audience questions. Presented in partnership with AstraZeneca.

Friday, October 5

 7:30-9:00am

  Which Came First — the Target or the Drug?  A Debate on the Changing Role of Basic Science in Determining the Future of Medical Research. How are cures on the cusp realized? (Breakfast Tutorial - From the Lab to You)
    Putting Your Genes to the Test. How can we benefit from new genetic tests? Can they help us avoid illness altogether? (Breakfast Tutorial - State of the Art Medical Science)
    What’s Hot: Emerging Trends in Biotech, Pharma and Health IT. What science of today will make you healthier tomorrow? (Breakfast Tutorial - From the Lab to You)
Science Education: How do you Train a Doctor for the 21st Century? Are we meeting our competitive needs? Are we keeping up with the rest of the world? Are our training methods sufficient to the needs of the profession in the 21st Century? (Breakfast Tutorial - The Art and Humanity of Medicine)
   

New International Approaches to Drug Discovery and Healthcare Delivery. The world of pharmaceutical discovery and healthcare delivery is rapidly changing. Pharmaceutical companies that have long insisted that discovery research, development and sales be vertically integrated and closely contained are radically restructuring and outsourcing fundamental processes including target validation, chemical library construction, screening, lead optimization, clinical trials design and implementation, manufacturing and sales. A leading driver of these changes, Dr. Robert Armstrong of Eli Lilly Company will explain the advantages and concerns of this transformation. Healthcare delivery in developed and developing countries is also being restructured. Dr. James D'Orta of Consumer Health Services will describe efforts to bring healthcare services closer to patients by placing doctors and nurse paractioners in walk-in clinics in pharmacies. Dr. Marie Charles will describe a program to bring doctors to countries around the world to train physicians and healthcare workers in management of HIV/AIDS and other infectious diseases.

       

 9:15-11:00am

  Plenary Session: Battling Cancer.  For decades the cure for cancer has seemed just around the corner. Diagnostic advances have facilitated earlier detection, and radiation and chemotherapy have become more precise, but the cure still remains elusive. Why? What are the barriers we must overcome? (Plenary - Frontiers in Medicine)
       

 11:15-12:30pm

  Plenary Session: Cracking the Code: Life and Wellness in the Genomic Age.  Has the unlocking of the genetic code changed the way you see health and illness? If it hasn’t yet, it soon will. The code holds the answers to the future of medicine. What are the social, political, and medical implications of understanding DNA? (Plenary - State of the Art Medical Science)
       

12:30-2:00pm

Lunch and Plenary Session: Stopping the Super Bugs. Andrew Speaker, the tuberculosis-infected Atlanta lawyer, showed the world how alarming just one individual with a particularly potent infection can be. Many familiar diseases such as tuberculosis and malaria are emerging in novel and more dangerous drug-resistant forms, while new diseases such as SARS and Bird Flu are growing threats. How will public health authorities, your doctor, and you guard against these emerging infections? (Lunch Plenary - Frontiers in Medicine)
Lunch and Plenary Session: Innovation and Incentives: Can Breakthrough Science Survive Market Forces? Today we rely largely on for-profit companies to develop new drugs. But do market forces alone bring us the medicines we need? Recognizing that profit drives innovation, we consider public-private partnerships and other models to help sustain promising research. (Lunch Plenary - From the Lab to You)
   

2:15-3:45pm

The New Scientific Power: The Role of Philanthropy, Patient Advocates, and Other Novel Partners in Changing our Medical Future. Increasingly, philanthropic dollars are supporting medical science research and efforts to eradicate diseases, patient advocates are pressing for the reallocation of resources, and novel partnerships are making new ventures possible through shared risk. (Tutorial - From the Lab to You)
Genomes. Every day the genome is providing new clues into how species evolve, how disease is controlled and how new illnesses emerge. Join us as we survey the latest discoveries. (Tutorial - State of the Art Medical Science)
Today's Scientific Renaissance. The Italian Renaissance of the 15th century represented a vibrant convergence of the arts and sciences that has shaped the modern era. Today, we are on the cusp of a 21st century scientific renaissance marked by accelerated advancement in neuroscience, theoretical physics and genetics, a culture war between science and religion, and the application of science as a tool for social change and economic development. Adam Bly, Founder and Editor-in-Chief of Seed magazine, and John Maeda, Associate Director of Research at the MIT Media Lab, will address what is catalyzing this cultural shift, who is leading it, and where we are going from here. (Tutorial - The Art and Humanity of Medicine)
The Immune System: Nature's Defense. A strong immune system is the unsung hero of health. Immune system cells are involved in almost every aspect of human biology and are among the body’s most complex. Discoveries in the emerging field of immunity are unlocking important clues to battling infections, tumors, and auto-immune disease. (Tutorial - Frontiers in Medicine)

Patients Without Borders: Medical Tourism and Health Services Delivery in India.  Health services in India are experiencing a remarkable transformation. The terms “medical tourism” and “medical outsourcing” are used to describe high quality, low cost medical procedures performed in India for foreigners. These services are available to wealthy Indians as well. A second transformation of health services in India is also underway, directed at providing services to the poor and the middle class. Private, for-profit hospitals have redesigned procedures and processes to incorporate the latest diagnostic and communications technologies, facilitating high-volume services and lower costs to the ultimate benefit of patients. Hospital and health services leaders from India will discuss these and other advances. Innovations made in providing affordable health services in India may be applicable in the United States and other developed countries. (Breakfast Tutorial - International Science)

   

4:00-5:30pm

The Ticking Cellular Clock. The life cycle of the cell, also called the "cellular clock," influences everything from cancer to aging. Hear the latest insights on how a cell controls the cycles of its life, including birth, regeneration and death. (Tutorial - State of the Art Medical Science)
Organ Transplantation: Advances, Barriers and Ethics. More than half a century into the era of transplantation, rejection remains the single biggest challenge. Our panel considers advances in immune system tolerance and other strategies to reduce the number of people on organ donor waitlists. (Tutorial - Frontiers in Medicine)
The Emerging Science of Mood: Understanding Depression and Mania. Many of our creative artists and intellectuals as well as countless family and friends have struggled with disorders of mood. Come hear about the science of mood and its implications for society. (Tutorial - The Art and Humanity of Medicine)
The Electronic Prescription: How Information Technology Will Change the Face of Medicine. Health IT promises to transform almost every area of medicine, including electronic medical records, data mining for evidence-based medicine, new diagnostics, and robo-surgery. Computer programming is becoming as essential as anatomy. Learn how these innovations are becoming realities. (Tutorial - Frontiers in Medicine)
Diabetes and The Sugar Syndrome: Is Sugar the New Cholesterol? Diabetes is becoming more prevalent despite the fact that most people know to avoid it. What's becoming increasingly clear is that the time to control your blood sugar is now. Learn how genetics and molecular biology are changing our view of who is at risk and how they should be treated. Increasingly, international trends in the prevalence of Type I and Type II diabetes have much to teach us about our medical future. Scientists are uncovering new clues into the genetics, social factors, and lifestyle choices that are increasing the rates of glucose intolerance. (Tutorial - Science and Prevention)
   

5:30-7:00pm

Dinner and Free Time

Art Exhibits (Paepcke Gallery)

American Transplant Foundation Reception  (Paepcke Gallery and Lobby)

Navigenics Reception (Meadows Restaurant)
Join the team from Navigenics for a reception at the Meadows Restaurant and a chance to hear about the latest in genetic testing technologies. Thanks to monumental advancements in genomic science, medicine and technology, it is now possible to determine individual genetic predispositions for certain common diseases and conditions, perhaps years or even decades before they develop. This personal genetic information offers critical insights that can enable individuals to take action to delay or even prevent an illness altogether. Navigenics is preparing to launch a customized genomic testing service that will allow you to know what your risks of the future are today. Come join Dietrich Stephan, PhD (Co-founder and Chief Science Officer, Navigenics),  Mari Baker (CEO, Navigenics), and Amy DuRoss (Head of Policy and Business Affairs, Navigenics) to learn how you can become a part of the new proactive medicine movement.

7:00-9:30pm

A Two-Part Program:  HIV and the World and Applying New Science to Global Health.

Keynote: HIV and the World. Over the past decade, advances in treatment have slowed the progression of HIV infection to AIDS and led to decreases in deaths in developed nations, but the disease continues to ravage populations in Africa and other parts of the world. Improving access to antiretrovirals is only part of the answer. We examine prevention efforts and other best practices. (Keynote - Frontiers in Medicine)

 

Evening Special Event: Applying New Science to Global Health. Global health experts outline the most critical global health problems, explore which among them can be solved only with new science and technology, and consider how to implement those solutions.

Saturday, October 6

 7:30-9:00am

  Biomedical Ethics. From stem cells to genetic enhancements, from planning for pandemic flu to treating mental disorders, advances in biomedicine inevitably pose major social and ethical challenges.  How are we to think about these ethical challenges? This session will explore some of the major ethical issues in biomedicine. (Breakfast Tutorial - The Art and Humanity of Medicine)
    Food Fights: How Politics are Changing our Diet. From states barring trans fats to schools combating sugar, the fight over food has never been more political. And lurking behind this discussion is a philosophical debate about the role of personal responsibility in health. (Breakfast Tutorial - Science and Prevention)
       

 9:15-11:00am

  Plenary Session: Health, Humanity and Politics: Prospects for Reform. As election season looms, many Americans are wondering if the next President can change health care for the better given the many competing interests. We go behind the arguments to consider what health care would look like if we had a blank sheet and politicians could be trusted to do the right thing. (Plenary - The Art and Humanity of Medicine)
       

 11:15-12:30pm

  Health Diplomacy: The United States and Iran. Building on a partnership with the U.S. State Department and International Visitors Program, this session will feature American and Iranian health experts exploring ways in which to strengthen their respective public health systems through shared knowledge and cooperative efforts. Our panel will survey current trends, challenges and achievements in public health in the two countries, touching on HIV/AIDS, addiction, cardiovascular disease and tuberculosis. (Tutorial - International Science)
    The Changing Face of Investments in Health: A Conversation about Maximizing your Investment Dollar. With the declining number of new chemical entities and therefore new drugs being introduced, what is the future of the biomedical enterprise? Should investors turn to emerging biotech or back big pharmaceutical companies? Learn about this rapidly changing field. (Tutorial - From the Lab to You)
Medical Diplomacy: Winning Hearts and Minds Around the World. With AIDS reaching near catastrophic proportions in Africa and India and with American intervention in the Middle East and other hot spots resulting in health and wellness issues, Tommy Thompson's responsibilities as Secretary of Health and Human Services were both manifold and global. Former Secretary Thompson will share his experiences as the U.S. global medical diplomat, relating stories about how medical emergencies and catastrophes abroad affect the United States – and what should be done about them.
The Female Body. Women live longer than men and yet common diseases, such as heart disease, often go undiagnosed in women. Learn about the controversies surrounding how diseases that affect women are researched and how the fruits of these studies reach the women who need them. From hormone replacement therapy to breast cancer to heart disease to reproductive choices, women face a range of distinctive health risks. How will we prepare for these risks in the future? (Tutorial - Frontiers in Medicine)
       

12:30-2:00pm

Lunch and Closing Plenary: Winning the Game of Life. Modern medicine is no longer just about healing the sick. Increasingly, it is about becoming super-well. With new medical advances, what does it mean to be healthy and how do you know you have lived a good life? (Closing Plenary - The Art and Humanity of Medicine)

________________________________

Sessions are listed below with the panelists included, catergorized under their track headings.

State of the Art Medical Science: The critical research you may not have heard of but need to know.

  • Beyond the X-Ray: 21st Century Imaging.
    Panelists:
    • Robert Honigberg, MD; Chief Medical Officer, GE Healthcare
    • Richard Robb, PhD; Director of the Mayo Biomedical Imaging Resource, Mayo Clinic College of Medicine
    • Brian Thiele, MD; Professor of Surgery, University of Queensland Australia
    • Moderator: Franklyn Prendergast, MD, PhD, Professor of Pharmacology and Former Director, Mayo Clinic Cancer Center
    • Introducer: Elizabeth Baker Keffer; Publisher, The Atlantic

  • The Ticking Cellular Clock.
    Panelists:
    • Bruce Stillman, PhD; President and CEO, Cold Spring Harbor Laboratory
    • Greg Verdine, PhD; Harvard College Professor, Department of Chemistry and Chemical Biology, Harvard University
    • Jonathan Weissman, PhD; Professor of Cellular and Molecular Pharmacology and of Biochemistry and Biophysics, UCSF
    • Moderator: Franklyn Prendergast, MD, PhD; Professor of Pharmacology and Former Director, Mayo Clinic Cancer Center

  • The Last Frontier: The Mind.
    Panelists:
    • Regis Kelly, PhD; Executive Director, California Institute for Quantitative Biomedical Research (QB3)
    • Cynthia Kenyon, PhD; Professor of Neuroscience, University of California San Francisco
    • Daniel Weinberger, MD; Senior Investigator, The National Institute of Mental Health
    • Moderator: Eve Nichols; Vice President for Science, Fidelity Foundation

  • Genomes.
    Panelists:
    • Bruce Stillman, PhD; President and CEO, Cold Spring Harbor Laboratory
    • Nathan Wolfe, PhD; Professor of Epidemiology, School of Public Health, University of California Los Angeles
    • Moderator: Sharon Begley; Science Columnist, Newsweek

  • Tailor-Made Medicine: How genomic science will lead to personalizing treatment and cures.
    Panelists:
    • Steven Gutman, MD, MBA; Director, Office of In Vitro Diagnostic Device Evaluation and Patient Safety, U.S. Food and Drug Administration
    • James Madara, MD; Chief Executive Officer, University of Chicago Medical Center
    • Gilbert Omenn, MD, PhD; Professor of Medicine, Genetics, Public Health and Computational Biology, University of Michigan Medical School
    • Wayne Rosenkrans, Jr., PhD; Scientific and Medical Strategy Director, External Medical Relations, AstraZeneca Pharmaceuticals
    • Moderator: Greg Simon, JD; President, FasterCures

  • The Promise of Stem Cells: Will the Body Become a Renewable Resource?
    Panelists:
    • Anthony Atala, MD; Director, Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine
    • Tannishtha Reya, PhD; Assistant Professor of Pharmacology and Cancer Biology, Duke University School of Medicine
    • David Scadden, MD; Gerald and Darlene Jordan Professor of Medicine, Massachusetts General Hospital
    • Irv Weissman, MD; Director, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University
    • Moderator: Clifton Leaf, MFA; Journalist and Former Executive Editor, Fortune

  • Cracking the Code: Life and Wellness in the Genomic Age.
    Panelists:
    • J. Michael Bishop, MD; Chancellor, University of California, San Francisco
    • Stanley Cohen, MD; Kwoh-Ting Li Professor in the School of Medicine, Stanford University
    • Kathy Hudson, PhD; Founder and Director, The Genetics and Public Policy Center, Johns Hopkins University
    • Robert Tjian, PhD; Professor of Biochemistry and Molecular Biology, University of California, Berkeley
    • Irv Weissman, MD; Director, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University
    • Moderator: Susan Dentzer; Health Correspondent, The NewsHour with Jim Lehrer
    • Introducer: Michelle McMurry, MD, PhD; Director, Health, Biomedical Science and Society Initiative, The Aspen Institute

  • Putting Your Genes to the Test.
    Panelists:
    • David Agus, MD; Research Director, Louis Warschaw Prostate Cancer Center, Cedars-Sinai Medical Center
    • Stuart Hogarth; Research Associate, Department of Public Health and Primary Care, Cambridge University
    • Kathy Hudson, PhD; Founder and Director, The Genetics and Public Policy Center, Johns Hopkins University
    • Greg Simon, JD; President, FasterCures
    • Moderator: Sharon Begley; Science Columnist, Newsweek

To the Top

Frontiers in Medicine: What's on the horizon?
  • The Mysterious Human Heart (daytime panel).
    Panelists:
    • Betsy Nabel, MD; Director, National Heart, Lung, Blood Institute
    • Eric Rose, MD; Professor and Chairman, Department of Surgery, Columbia University College of Physicians and Surgeons
    • Douglas P. Zipes, MD; Emeritus Director, Cardiology Division, Indiana University School of Medicine
    • Moderator: David Grubin; President, David Grubin Productions
    • Introducer: Elizabeth Baker Keffer; Publisher, The Atlantic

  • The Electronic Prescription: How Information Technology Will Change the Face of Medicine.
    Panelists:
    • Zoë Baird, JD; President, The Markle Foundation
    • Bill Frist, MD; Former Senate Majority Leader
    • Franklin Raines, JD; Vice Chairman, Revolution Health Group Board of Directors
    • Nathan Wolfe, PhD; Professor of Epidemiology, School of Public Health, University of California Los Angeles
    • Moderator: R. Bartley Moore; Executive Director of Research, Atlantic Media
    • Introducer: Deborah Cunningham; Executive Director, Marketing, The Atlantic

  • The Damaged Brain: The Fight Against Neurodegeneration. 
    Panelists:
    • Scott Johnson, MBA; President and Founder, Myelin Repair Foundation
    • Trent Nichols, MD; Founder, Center for Nutrition and Digestive Disorders
    • Edwin Stone, MD, PhD; Director, Carver Family Center for Macular Degeneration, University of Iowa
    • Moderator: Ron Winslow; Deputy Editor, Health and Science, The Wall Street Journal

  • The Immune System: Nature's Defense.
    Panelists:
    • Andrea Califano, PhD; Professor and Associate Director, Herbert Irving Comprehensive Cancer Center
    • Gary Nabel, MD, PhD; Director, Vaccine Research Center, National Institutes of Health
    • Steven Rosenberg, MD, PhD; Chief, Surgery Branch, National Cancer Institute
    • Moderator: Irv Weissman, MD; Director, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University

  • HIV and the World.
    Panelists:
    • Anthony Fauci, MD; Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health
    • Mary Robinson, LLB, LLM; President, Realizing Rights: The Ethical Globalization Initiative, The Aspen Institute
    • Moderator: Clive Crook; Senior Editor, The Atlantic
    • Introducer: Deborah Cunningham; Executive Director, Marketing, The Atlantic

  • The Female Body.
    Panelists:
    • Alan Altman, MD; Assistant Clinical Professor of Obstetrics, Gynecology and Reprodcutive Biology, Harvard Medical School
    • Ruth Faden, PhD, MPH; Executive Director, Johns Hopkins Berman Institute of Bioethics
    • Silvia Formenti, MD; Chairman of the Department of Radiation Oncology, NYU School of Medicine
    • Kathy Hudson, PhD; Founder and Director, The Genetics and Public Policy Center, Johns Hopkins University
    • Moderator: Glenda Greenwald; Founder and Chair Emeritus, Aspen Center for Integral Health

  • Stopping the Super Bugs.
    Panelists:
    • Ronald Atlas, PhD; Co-Director, Center for Health Hazards Preparedness, University of Louisville
    • Stanley Cohen, MD; Kwoh-Ting Li Professor in the School of Medicine, Stanford University
    • Rita Colwell, PhD; Senior Advisor and Honorary Chairperson, Canon U.S. Life Sciences  
    • Anthony Fauci, MD; Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health
    • Gary Nabel, MD, PhD; Director, Vaccine Research Center, National Institutes of Health
    • Nathan Wolfe, PhD; Professor of Epidemiology, School of Public Health, University of California Los Angeles
    • Moderator: Margaret Hamburg, MD; Senior Scientist, Nuclear Threat Initiative

  • Pandemic Influenza.
    Panelists:
    • Ronald Atlas, PhD; Co-Director, Center for Health Hazards Preparedness, University of Louisville
    • John Barry; Author of The Great Influenza: The Epic Story of the Deadliest Plague in History
    • Margaret Hamburg, MD; Senior Scientist, Nuclear Threat Initiative
    • David Nabarro, MD, MSc; Senior Coordinator for Avian and Human Influenza, United Nations
    • Moderator: Stewart Simonson, JD; Vice President for Global Public Health Preparedness, Constella Group, LLC

  • Cancer and the Sexes
       Panelists:
    • David Agus, MD; Research Director, Louis Warschaw Prostate Cancer Center, Cedars-Sinai Medical Center
    • Silvia Formenti, MD; Chairman of the Department of Radiation Oncology, NYU School of Medicine
    • Larry Norton, MD; Norna S. Sarofim Chair in Clinical Oncology, Memorial Sloan-Kettering Cancer Center
    • Gilbert Omenn, MD, PhD; Professor of Medicine, Genetics, Public Health and Computational Biology, University of Michigan Medical School
    • Moderator: Ezekiel Emanuel, MD, PhD; Director, Department of Clinical Bioethics, National Institutes of Health 

  • Battling Cancer.
    Panelists:
    • J. Michael Bishop, MD; Chancellor, University of California, San Francisco
    • Hala Moddelmog; President and Chief Executive Officer, Susan G. Komen for the Cure
    • Max Coppes, PhD, MBA; Executive Director, Center for Cancer and Blood Disorders, Children's National Medical Center
    • Henry Friedman, MD; Deputy Director, Preston Robert Tisch Brain Tumor Center, Duke University Medical Center
    • Michael Milken, MBA; Founder and Chairman, FasterCures
    • John Niederhuber, MD; Director, National Cancer Institute
    • Steven Rosenberg, MD, PhD; Chief, Surgery Branch, National Cancer Institute
    • Moderator: Clifton Leaf, MFA; Journalist and Former Executive Editor, Fortune

  • Science Versus the Biological Clock.
    Panelists:
    • William Colby, JD; Senior Fellow, National Hospice and Palliative Care Organization
    • Cynthia Kenyon, PhD; Professor of Neuroscience, University of California San Francisco
    • Stephanie Lederman, EdM; Executive Director, American Federation for Aging Research
    • Moderator: Nigel Cameron, PhD; President, Institute on Biotechnology and the Human Future

  • Organ Transplantation: Advances, Barriers and Ethics.
    Panelists:
    • Roy Calne, MD; Professor of Surgery Emeritus, Cambridge University
    • Peter McMurry; Cystic Fibrosis patient, and long time organ transplant recipient survivor
    • Mark Siegler, MD; Director, MacLean Center for Clinical Medical Ethics, University of Chicago
    • Moderator: Ron Winslow; Deputy Editor, Health and Science, The Wall Street Journal

To the Top

From the Lab to You: How hard science becomes health care.

  • Which Came First the Target or the Drug?
    Panelists:
    • Peter Agre, MD; Vice Chancellor for Science and Technology, Duke University Medical Center
    • Mark McClellan, MD, PhD; Visiting Senior Fellow, AEI-Brookings Joint Center for Regulatory Studies 
    • Michael Milken, MBA; Founder and Chairman, FasterCures
    • Robert Tjian, PhD; Professor of Biochemistry and Molecular Biology, University of California, Berkeley
    • Moderator: Mary Woolley; President and CEO, Research!America

  • The New Scientific Power: The Role of Philanthropy, Patient Advocates, and Other Novel Partners in Changing our Medical Future.
    Panelists:
    • Hala Moddelmog; President and Chief Executive Officer, Susan G. Komen for the Cure
    • Scott Johnson, MBA; President and Founder, Myelin Repair Foundation
    • Richard Klausner, MD; Managing Partner, The Column Group; Former Global Health Director, Bill & Melinda Gates Foundation
    • Robert Klein, JD; Chairman, California Institute for Regenerative Medicine
    • Amy McGuire Porter; Executive Director, Foundation for the National Institutes of Health
    • Moderator: Susan Dentzer; Health Correspondent, The NewsHour with Jim Lehrer

  • Getting What We Pay For: The Impact of Declining Public Investment in Medical Science Research
    Panelists:
    • Rita Colwell, PhD; Senior Advisor and Honorary Chairperson, Canon U.S. Life Sciences
    • Dan Crippen, PhD; Former Director, Congressional Budget Office
    • Joan Goldberg; Executive Director, American Society for Cell Biology
    • Peter Orszag, PhD, MSc; Director, Congressional Budget Office
    • John Porter, JD; Partner, Hogan & Hartson LLP
    • Moderator: Stuart Smith, JD, MBA; Managing Director and Head of Health Care, Investment Banking Department, Credit Suisse

  • What’s Hot: Emerging Trends in Biotech, Pharma and Health IT. 
    Panelists:
    • James Greenwood; President and Chief Executive Officer, Biotechnology Industry Organization
    • Caroline Kovac, PhD; Managing Director, Burrill & Company
    • Andrew Schiff, MD; Managing Director, Aisling Capital
    • Moderator: Franklin Raines, JD; Vice Chairman, Revolution Health Group Board of Directors

  • Innovation and Incentives: Can Breakthrough Science Survive Market Forces? 
    Panelists:
    • Harvey Fineberg, MD, PhD; President, The Institute of Medicine
    • Craig Fuller; Executive Vice President, APCO Worldwide
    • James Greenwood; President and Chief Executive Officer, Biotechnology Industry Organization
    • Jennifer Jarrett, MBA; Director, Health Care Group, Investment Banking Department, Credit Suisse
    • Richard Klausner, MD; Managing Partner, The Column Group; Former Global Health Director, Bill & Melinda Gates Foundation
    • Moderator: Robert Klein, JD; Chairman, California Institute for Regenerative Medicine

  • The Changing Face of Investments in Health: A Conversation about Maximizing your Investment Dollar.
    Panelists:
    • Robert W. Armstrong, PhD; Vice President of Global External Research and Development, Eli Lilly Company
    • Jessica Owens, MBA; Partner, Kleiner Perkins Caufield & Byers
    • Andrew Schiff, MD; Managing Director, Aisling Capital
    • Moderator: Rob Mashal, MD; CEO, Alinea Pharmaceuticals, Inc.

To the Top

Science and Prevention: What you can (and should) be doing to enhance your health.

  • Fitness and Nutrition: The Science of Metabolism.
    Panelists: 
    • C. Ronald Kahn, MD; Mary K. Iacocca Professor of Medicine, Harvard Medical School Joslin Diabetes Center
    • Paul Zimmet, AO, MD, PhD; Director, International Diabetes Institute
    • Moderator: Susan Brink; Health Staff Writer, Los Angeles Times

  • The Future of Nutrition: What your Body Needs You to Know Now.
    Panelists:
    • Dean Ornish, MD; Founder and President, Preventive Medicine Research Institute
    • Steven Zeisel, MD, PhD; Kenan Distinguished University Professor, UNC-Chapel Hill School of Public Health
    • Moderator: Catherine Arnold, MBA, MHA; Director and Senior Analyst, U.S. Major Pharmaceuticals, Credit Suisse

  • Diabetes and The Sugar Syndrome: Is Sugar the New Cholesterol? 
    Panelists:
    • Tom Hughes, PhD; Head of Diabetes and Metabolism Research, Novartis Institutes for Biomedical Research, Inc.
    • C. Ronald Kahn, MD; Mary K. Iacocca Professor of Medicine, Harvard Medical School Joslin Diabetes Center
    • Jay Skyler, MD; Professor of Medicine, Pediatrics and Psychology, University of Miami Miller School of Medicine
    • Paul Zimmet, AO, MD, PhD; Director, International Diabetes Institute
    • Moderator: Rob Mashal, MD; CEO, Alinea Pharmaceuticals, Inc.

  • Food Fights: How Politics are Changing our Diet. 
    Panelists:
    • Glenda Greenwald; Founder and Chair Emeritus, Aspen Center for Integral Health
    • Eric Schlosser; Author of Fast Food Nation
    • Jay Skyler, MD; Professor of Medicine, Pediatrics and Psychology, University of Miami Miller School of Medicine
    • Moderator: Susan Brink; Health Staff Writer, Los Angeles Times
    • IntroducerDeborah Cunningham; Executive Director, Marketing, The Atlantic 

To the Top

International Science

  • Health Diplomacy: The United States and Iran.
    Panelists:
    • Arash Alaei, MD, MPH; Director, International Education and Research Cooperation, Iranian National Research Institute of Tuberculosis and Lung Disease
    • Kamiar Alaei, MD, MPH, MS; Visiting Fellow, Harvard University School of Public Health
    • Kaveh Khoshnood, PhD; Assistant Professor in Public Health Practice, Yale University School of Public Health
    • Navid Madani, PhD; Instructor and Staff Scientist, Harvard Medical School Dana-Farber Cancer Institute
    • Stewart Simonson, JD; Vice President for Global Public Health Preparedness, Constella Group, LLC
    • Moderator: Toni Verstandig; Director, Middle East Strategy Group, The Aspen Institute

  • International Scientific Cooperation.
    Panelists:
    • Harvey Fineberg, MD, PhD; President, The Institute of Medicine
    • Jennifer Jarrett, MBA; Director, Health Care Group, Investment Banking Department, Credit Suisse  
    • Alan Leshner, PhD; CEO, American Association for the Advancement of Science
    • R. Sanders Williams, MD; Senior Vice Chancellor for Academic Affairs, Duke University School of Medicine
    • Moderator: Ellis Rubinstein; President, New York Academy of Sciences

  • Patients Without Borders: Medical Tourism and Health Services Delivery in India.
    Panelists: 
    • Pervez Ahmed, MBBS; Executive Director of Medical Operations, Max Healthcare Ltd.
    • James D'Orta, MD; Founder, Chairman and CEO, Consumer Health Services, Inc.
    • William A. Haseltine, PhD; President, The Haseltine Foundation for Medical Sciences and the Arts
    • Krishna Reddy; CEO, Care Hospital
    • Sri SivaKumar; Chief Executive, ITC Limited
    • Priyadarshi Tiwari, MD; Chief of Community Health & Wellness Services, Care Hospitals
    • Moderator: William A. Haseltine, PhD; President, The Haseltine Foundation for Medical Sciences and the Arts

  • New International Approaches to Drug Discovery and Healthcare Delivery
    Panelists:
    • Robert W. Armstrong, PhD; Vice President of Global External Research and Development, Eli Lilly Company
    • Marie Charles, MD; Chair and CEO, International Centre for Equal Healthcare Access
    • James D'Orta, MD; Founder, Chairman and CEO, Consumer Health Services, Inc.
    • William A. Haseltine, PhD; President, The Haseltine Foundation for Medical Sciences and the Arts
    • Moderator: William A. Haseltine, PhD; President, The Haseltine Foundation for Medical Sciences and the Arts 
  • Global Scientific Investment.
    Panelists:
    • Alice Dautry, PhD; President, Institut Pasteur
    • Ellis Rubinstein; President, New York Academy of Sciences
    • Moderator: Norman Neureiter, PhD; Director, Center for Science, Technology and Security Policy, American Association for the Advancement of Science
    • Introducer: Jennifer Jarrett, MBA; Director, Health Care Group, Investment Banking Department, Credit Suisse

  • Dangerous Liaisons: The Intersection of Environmental, Animal and Human Health.
    Panelists:
    • Bill Frist, MD; Former Senate Majority Leader
    • Introducer: Stewart Simonson, JD; Vice President for Global Public Health Preparedness, Constella Group, LLC

To the Top

The Art and Humanity of Medicine

  • Health, Humanity and Politics: Prospects for Reform.
    Panelists: 
    • Bill Frist, MD; Former Senate Majority Leader
    • Mark Ganz; President and CEO, The Regence Group
    • Elizabeth Teisberg, PhD; Co-Author, Redefining Health Care
    • Tommy Thompson, JD; Former Secretary of Health and Human Services
    • Moderator: Ken Weakley, MBA; Managing Director and Senior Healthcare Services Analyst, Credit Suisse
    • Introducer: Michelle McMurry, MD, PhD; Director, Health, Biomedical Science and Society Initiative, The Aspen Institute

  • Easing the Burden: Does Health Care Cost Too Much and How Do We Pay for It?
    Panelists:
    • Dan Crippen, PhD; Former Director, Congressional Budget Office
    • Ezekiel Emanuel, MD, PhD; Director, Department of Bioethics, National Institutes of Health
    • Bill Frist, MD; Former Senate Majority Leader
    • Peter Orszag, PhD, MSc; Director, Congressional Budget Office
    • Moderator: Ron Winslow; Deputy Editor, Health and Science, The Wall Street Journal

  • The Human Element: A Candid Conversation about Pioneers of Modern Medicine.
    Panelists:
    • Peter Agre, MD; Vice Chancellor for Science and Technology, Duke University Medical Center
    • J. Michael Bishop, MD; Chancellor, University of California, San Francisco
    • Neen Hunt, EdD; President, The Lasker Foundation
    • Moderator: Elliot Gerson; Executive Vice President, Seminars and Public Programs, The Aspen Institute

  • Winning the Game of Life. 
    Panelists:
    • Ezekiel Emanuel, MD, PhD; Director, Department of Bioethics, National Institutes of Health
    • Betsy Nabel, MD; Director, National Heart, Lung, Blood Institute
    • John Parr, JD; Co-Founder, Civic Results
    • Terrie Fox Wetle, PhD; President, American Federation for Aging Research  
    • ModeratorMichelle McMurry, MD, PhD; Director, Health, Biomedical Science and Society Initiative, The Aspen Institute

  • Science Education: How do you Train a Doctor for the 21st Century?
    Panelists:
    • Darrell Kirch, MD; President and CEO, Association of American Medical Colleges
    • Alan Leshner, PhD; CEO, American Association for the Advancement of Science
    • James Madara, MD; CEO, University of Chicago Medical Center
    • Moderator: Susan Brink; Health Staff Writer, Los Angeles Times
  • Biomedical Ethics.
    Panelists:
    • Nigel Cameron, PhD; President, Institute on Biotechnology and the Human Future
    • Einer Elhauge, JD; Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University
    • Ruth Faden, PhD, MPH; Executive Director, Johns Hopkins Berman Institute of Bioethics
    • Frances Kamm, PhD; Littauer Professor of Philosophy and Public Policy, Kennedy School of Government, Harvard University
    • Mark Siegler, MD; Director, MacLean Center for Clinical Medical Ethics, University of Chicago
    • Moderator: Ezekiel Emanuel, MD, PhD; Director, Department of Bioethics, National Institutes of Health

  • The Hospital of the Future.
    Panelists:
    • David Eddy, MD, PhD; Founder and Chief Medical Officer, Archimedes, Inc.
    • Joe Hogan, MBA; President and CEO, GE Healthcare
    • John Maeda, PhD, MBA; Associate Director of Research, MIT Media Lab
    • Ken Weakley, MBA; Managing Director and Senior Healthcare Services Analyst, Credit Suisse 
    • Moderator: Harvey Fineberg, MD, PhD; President, The Institute of Medicine

  • From the Front Lines: Post-Traumatic Stress Disorder and the Legacy of Iraq.
    Panelists:
    • Charles Figley, PhD; Director, Florida State Traumatology Institute
    • George-Andreas Pogany; Founder, Just One Wounded Warrior
    • Steven Southwick, MD; Professor of Psychiatry, Yale Child Study Center, Yale University School of Medicine
    • Jennifer Vasterling, PhD; Chief of Psychology and Clinical Investigator, National Center for PTSD
    • Moderator: Barbara Romberg, PhD; Executive Director, Give an Hour

  • Today's Scientific Renaissance.
    Panelists
    • Adam Bly; Chief Executive Officer and Editor-in-Chief, Seed Media Group
    • John Maeda, PhD, MBA; Associate Director of Research, MIT Media Lab
    • ModeratorR. Bartley Moore; Executive Director of Research, Atlantic Media

  • The Emerging Science of Mood: Understanding Depression and Mania.
    Panelists:
    • Alan Leshner, PhD; CEO, American Association for the Advancement of Science
    • Nora Volkow, MD; Director, National Institute on Drug Abuse
    • Moderator: Not Yet Assigned
    • Introducer: Wayne Rosenkrans, Jr., PhD; Scientific and Medical Strategy Director, External Medical Relations, AstraZeneca Pharmaceuticals

  • Great Expectations: American Attitudes toward Personal Responsibility and Medicine.
    Panelists:
    • Craig Fuller; Executive Vice President, APCO Worldwide
    • Mary Woolley; President and CEO, Research!America
    • Moderator: John Zogby; President and CEO, Zogby International

  • Medical Diplomacy: Winning Hearts and Minds Around the World.
    Panelists: 
    • Tommy Thompson, JD; Former Secretary of Health and Human Services

To the Top

Evening Special Events

  • Fast Food Nation: A Film Screening Hosted by Eric Schlosser.
    Panelists:
    • Eric Schlosser; Author and Journalist

  • The Mysterious Human Heart. 
    Panelists:
    • David Grubin; President, David Grubin Productions
    • Douglas P. Zipes, MD; Emeritus Director of the Cardiology Division, Indiana University School of Medicine
    • Introducer: Elizabeth Baker Keffer; Publisher, The Atlantic


  • Healthcare Re-imagined: Learning from Olympic Athletes.
    Panelists:
    • Joe Hogan, MBA; President & CEO, GE Healthcare
    • Jack Taunton, MD;  Chief Medical Officer, Vancouver Organizing Committee, 2010 Olympic Games
    • Malissa Wood, MD; Assistant Physician, Massachusetts General Hospital
    • Margaret Hunt, MS, ATC; U.S. Olympic Committee Games Medical Services Director
    • Picabo Street; U.S. Olympic gold medalist skier
    • Aaron Peirsol; U.S. Olympic gold medalist swimmer
    • Moderator: Jimmy Roberts, NBC sportscaster
  • Applying New Science to Global Health.
    Panelists:
    • Leonard Rubenstein, JD; President, Physicians for Human Rights
    • Richard Klausner, MD; Managing Partner, The Column Group; Former Global Health Director, Bill & Melinda Gates Foundation 
    • Moderator: Clive Crook; Senior Editor, The Atlantic

* No proceeds of ticket sales for The Aspen Health Forum events go to its sponsoring partners.

To the Top